Kidney disease drug added to PBS, helping 65,000 Australians

The federal government will add a medicine for chronic kidney disease into the Pharmaceutical Benefits Scheme. More than ...
Mirage News

Cheaper Medicine For Kidney Disease Patients

Tens of thousands of Australians living with chronic kidney disease will soon have access to more cheaper medicines on the Pharmaceutical Benefits ...

Chronic kidney treatment made cheaper for people like Franki

A diabetes drug that helps to slow kidney damage will be made available to more people more cheaply from Saturday, in the ...

Canadian public drug plan spending grew by $3.4 billion over 5 years, driven by use of higher-cost drugs

The latest edition of the Patented Medicine Prices Review Board (PMPRB) CompassRx report shows that prescription drug expenditure for public drug plans grew by 7.4% in 2022/23 to reach $14.1 billion, ...

Diabetes Drugs Might Counter Brain Decline In Early Alzheimer's Patients

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...
Knowridge Science Report

Two common drugs may boost brain health in early Alzheimer’s

Being diagnosed with Alzheimer’s disease or mild cognitive impairment can be overwhelming. These conditions slowly affect ...
Daily

Empagliflozin Fails to Preserve Beta-Cell Function After Gestational Diabetes: Trial Finds

Canada: Empagliflozin did not significantly preserve beta-cell function in women with a recent history of gestational diabetes, according to a randomized, placebo-controlled trial published in ...
Yahoo Finance

Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide

GAITHERSBURG, Md., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and ...